Skip to content

News Hub

The latest breaking stories

Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.

NewsMatch Alert

Discover the most important & comprehensive stories delivered directly to you daily.

  • Results Statistics
  • 16/10/2024
  • 21:20
The Lottery Corporation

Weekday Windfall Wednesday draw no. 4456, Lotto Strike draw no. 5525

Official Results Weekday Windfall Wednesday draw no. 4456 Draw Date: Wednesday, 16 October 2024 Drawn Numbers Winning Numbers (drawn order)[20] [39] [42] [26] [5] [25] Supplementary Numbers (drawn order)[36] [17] Division One Guaranteed Prize Offer (for up to 6 winners) $1,000,000.00 Total Prize Pool (Divisions 2 - 6) $1,430,585.70 Lotto Strike draw no. 5525 Drawn Numbers Winning Numbers (drawn order)[20] [39] [42] [26] Division One Prize Pool $1,201,326.03

  • Contains:
  • Biotechnology
  • 16/10/2024
  • 21:10
Moolec Science SA

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pea, Moolec…

  • Building Construction
  • 16/10/2024
  • 19:11
Allianz

Media Release: Allianz Calls for Greater Safety for Vulnerable Road Users in Urban Areas

Big vs. small in European cities: 70% of urban road deaths involve pedestrians, cyclists, or motorcyclists. One-third of accidents between trucks and pedestrians or…

  • Contains:
  • Indigenous, Women
  • 16/10/2024
  • 19:00
La Trobe University

La Trobe Professor inducted to Women’s Honour Roll

EMBARGOED UNTIL 7PM, October 16 2024 Professor Julie Andrews, Academic Director of Indigenous Research at LaTrobe University, has been inducted into the Victorian Honour Roll of Women as a Trailblazer in 2024.Professor Andrews is the only Victorian-descended Aboriginal female professor in a Victorian University and has been considered a trailblazer by the Yorta Yorta community since she studied at La Trobe in the 1990s. The first female Yorta Yorta Professor and a highly respected First Nations scholar, Professor Andrews’ contribution to Indigenous higher education and research culminated with the establishment of the Gabra Biik Wurruwila Wutja Indigenous Research Centre at…

  • CharitiesAidWelfare
  • 16/10/2024
  • 18:20
Highland

The Blue Lunch, Highland Property Group’s Charity Event, Reaches 10th Anniversary Milestone This October

It’s been 10 years since local property group Highland started a journey of raising funds for the Sydney Children’s Hospital Foundation at their bi-annual…

  • Contains:
  • Science
  • 16/10/2024
  • 18:11
IQM

IQM Selected to Deliver Two Advanced Quantum Computers as Part of Euro-Q-Exa Hybrid System

IQM will deliver two advanced Radiance quantum computers: a 54-qubit system in the second half of 2025, followed by a 150-qubit system at the…

  • Contains:
  • Biotechnology
  • 16/10/2024
  • 17:49
Dementia Australia

Rejection of drug a blow for Australians living with Alzheimer’s disease

Dementia Australia is disappointed by the initial decision of the Therapeutic Goods Administration (TGA) to reject Lecanemab for use in Australia. Lecanemab is a disease modifying treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment. Developed by pharmaceutical company Eisai, Lecanemab works by removing amyloid plaques from the brain and in doing so slows cognitive decline associated with the disease. Lecanemab is currently approved for use in the UK, USA, Japan, China, South Korea, Hong Kong, United Arab Emirates and Israel. In July it was rejected by the European Medicines Agency, a decision that…

  • Technology Innovation
  • 16/10/2024
  • 17:41
FPT Software

FPT Software Receives ISO 45001 Certification

HANOI, Vietnam–BUSINESS WIRE– Global IT leader FPT Software has achieved ISO 45001 certification, the international standard for occupational health and safety, across its twelve…

  • Contains:
  • Technology Innovation
  • 16/10/2024
  • 17:11
Megaport Limited

Megaport Expands to 14 More Data Centres Across Europe and Strengthens Operations Through Strategic Partnerships

New Points of Presence and partnerships with Portus Data Centers, NorthC Data Centers, and Sipartech drive Megaport’s growth across Europe BRISBANE, Australia–BUSINESS WIRE– Megaport…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.